Biogen Pharmachechem Industries Limited has submitted a regulatory disclosure to BSE Limited regarding an upcoming board meeting. The disclosure is made pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
A meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, 5th August 2026. The primary agenda for the meeting includes:
1. To approve and take on record the Un-Audited Financial Results of the Company for the first quarter ended on 30th June 2026.
2. Any other matter with the permission of the board which the Board may think fit.
The letter was signed by Kelash Bunkar, Director of the company, and was addressed to the Department of Corporate Services at BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001.
The company's CIN is L51100GJ1995PLC026702.